Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-12 5:24 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | Nikko Asset Management Americas Inc. | 8,273,223 11.82% | 1,175,126 (+16.56%) | View |
| 2020-02-12 06:02 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | Sumitomo Mitsui Trust Holdings Inc. | 8,273,223 11.82% | 1,175,126 (+16.56%) | View |
| 2020-02-07 11:30 am Sale | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 6,499,118 9.282% | -436,028 (-6.29%) | View |
| 2020-02-07 08:45 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | BlackRock Inc. BLK | 4,003,353 5.7% | 1,680,021 (+72.31%) | View |
| 2019-11-12 12:11 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | FMR LLC | 6,935,146 9.919% | 806,760 (+13.16%) | View |
| 2019-09-09 06:19 am Purchase | 13G | SERES THERAPEUTICS INC MCRB | Sumitomo Mitsui Trust Holdings Inc. | 7,098,097 10.15% | 7,098,097 (New Position) | View |
| 2019-09-06 2:17 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | Nikko Asset Management Americas Inc. | 7,098,097 10.15% | 7,098,097 (New Position) | View |
| 2019-07-10 4:25 pm Purchase | 13G | SERES THERAPEUTICS INC MCRB | BlackRock Inc. BLK | 2,323,332 3.3% | 66,474 (+2.95%) | View |
| 2019-06-28 4:30 pm Purchase | 13D | SERES THERAPEUTICS INC MCRB | Flagship VentureLabs IV LLC | 21,646,905 30.96% | 21,646,905 (New Position) | View |